Arcutis Biotherapeutics Shares Surge
This is a news story, published by Investor's Business Daily, that relates primarily to Arcutis Biotherapeutics news.
Arcutis Biotherapeutics news
For more Arcutis Biotherapeutics news, you can click here:
more Arcutis Biotherapeutics newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsInvestor's Business Daily news
For more news from Investor's Business Daily, you can click here:
more news from Investor's Business DailyAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Arcutis Biotherapeutics. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Arcutis stock investors news, psoriasis news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Topical steroidsInvestor's Business Daily
•Health
Health
Arcutis Biotherapeutics (ARQT) stock soars on hopes to eliminate eczema and psoriasis trade-off

50% Informative
Arcutis Biotherapeutics (ARQT) wants to eliminate a terrible trade-off for patients with eczema and psoriasis.
Topical steroids are a mainstay in treating itchy skin conditions.
But they come with a host of side effects, including skin thinning and spider veins.
VR Score
38
Informative language
37
Neutral language
12
Article tone
formal
Language
English
Language complexity
56
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links
Small business owner?